Uncover key drivers, emerging technologies, and competitive movements shaping the nicotinamide adenine dinucleotide market from 2026–2035 with trusted insights from The Business Research Company
By how much is the Nicotinamide Adenine Dinucleotide Market expected to grow between 2026 and 2030?
The nicotinamide adenine dinucleotide market size has seen substantial growth in recent years. It is anticipated to expand from $5.59 billion in 2025 to $6.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.1%. The expansion observed in the past can be ascribed to several factors, including the increasing demand for anti-aging supplements, the expanding research into cellular metabolism, a greater awareness of preventive healthcare, the enlargement of nutraceutical distribution channels, and the rising adoption of wellness and biohacking products.
The nicotinamide adenine dinucleotide market is anticipated to show significant expansion in the coming years, with its valuation projected to reach $11.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.8%. This expected growth within the forecast period stems from several factors, such as consumers’ increasing expenditure on solutions for longevity and vitality, the rising incorporation of NAD precursors into mainstream dietary supplements, the expanding presence of IV therapy and regenerative clinics, growing pharmaceutical interest in NAD for managing chronic illnesses, and the broader adoption of online personalized supplement programs. Prominent trends for this period include technological improvements in sustained-release and liposomal delivery methods, innovations in multi-ingredient formulations aimed at longevity, the development of NAD-based active ingredients for dermatology and skincare, research and advancements in therapeutic-grade NAD for addressing neurological and metabolic disorders, and progress in biomarker-driven personalized supplementation platforms.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30680&type=smp
Which Drivers Are Influencing Market Acceleration In The Nicotinamide Adenine Dinucleotide Market?
The increasing occurrence of age-related and metabolic disorders is anticipated to fuel the expansion of the nicotinamide adenine dinucleotide market. These health conditions, encompassing diabetes, obesity, cardiovascular diseases, and neurodegenerative disorders, are connected to aging, impaired metabolism, and cellular dysfunction. Their prevalence is on the rise as populations age and unhealthy lifestyle patterns, such as sedentary behavior, excessive calorie intake, and increasing obesity rates, become more widespread. Nicotinamide adenine dinucleotide assists in managing age-related and metabolic disorders by playing a vital role in cellular energy metabolism, mitochondrial function, and DNA repair processes, all of which are crucial for maintaining metabolic health and decelerating age-associated cellular decline. For example, in February 2025, the International Diabetes Federation, a Belgium-based nonprofit organization representing diabetes associations globally, projected that the number of people aged above 65 years with diabetes will reach 195.2 million, constituting 19.6% in 2030, and further rise to 276.2 million in 2045, underscoring a substantial increase in the diabetes burden within aging societies over the next 25 years with significant public health and economic ramifications. Consequently, the rising prevalence of age-related and metabolic disorders is propelling the growth of the nicotinamide adenine dinucleotide market.
What Segments Are Identified Within The Structure Of The Nicotinamide Adenine Dinucleotide Market?
The nicotinamide adenine dinucleotide market covered in this report is segmented –
1) By Product Type: Oral Nicotinamide Adenine Dinucleotide Supplements, Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules, Nicotinamide Adenine Dinucleotide Injection and Infusion Products, Specialized Anti-Aging and Metabolic Formulations, Nicotinamide Adenine Dinucleotide Precursors, Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations
2) By Grade: Food Grade, Pharmaceutical Grade, Other Grades
3) By Distribution Channel: Online and E-commerce, Offline Channels
4) By Application: Dietary Supplements and Wellness, Pharmaceuticals and Therapeutics, Cosmetics and Dermatology, Clinical IV Therapy and Regenerative Medicine, Research and Biotechnology
5) By End User: Individual Consumers, Healthcare Providers, Pharmaceutical Companies
Subsegments:
1) By Oral Nicotinamide Adenine Dinucleotide Supplements: Energy Support Tablets, Healthy Aging Capsules, Metabolism Support Powder, Immune Wellness Tablet, Cognitive Support Capsules
2) By Nicotinamide Adenine Dinucleotide And NADH Direct-Ingredient Capsules: Nicotinamide Adenine Dinucleotide Plus Capsules, Nicotinamide Adenine Dinucleotide Reduced Capsules, Cellular Energy Enhancement Capsules, Mitochondrial Support Capsules, High Potency Nicotinamide Adenine Dinucleotide Capsules
3) By Nicotinamide Adenine Dinucleotide Injection and Infusion Products: Intravenous Nicotinamide Adenine Dinucleotide Solutions, Intramuscular Nicotinamide Adenine Dinucleotide Shots, High Concentration Nicotinamide Adenine Dinucleotide Infusions, Detoxification Support Infusions, Regenerative Wellness Infusion Blends
4) By Specialized Anti-Aging and Metabolic Formulations: Cellular Regeneration Formulas, Mitochondrial Activation Formulas, Longevity Support Formulas, Metabolic Enhancement Formulas, Detoxification Support Formulas
5) By Nicotinamide Adenine Dinucleotide Precursors: Nicotinamide Mononucleotide Tablets, Nicotinamide Riboside Capsules, Nicotinamide Tablets, Nicotinamide Adenine Dinucleotide Pathway Support Powders, Healthy Aging Precursor Blends
5) By Topical and Cosmetic Nicotinamide Adenine Dinucleotide Formulations: Anti-Aging Facial Serums, Skin Repair Moisturizers, Brightening Facial Creams, Barrier Strengthening Lotions, Eye Area Rejuvenation Gels
What Industry Trends Are Transforming The Nicotinamide Adenine Dinucleotide Market?
Leading companies in the nicotinamide adenine dinucleotide market are prioritizing the development of advanced products, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to aid in anti-aging and improve skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements are products, either consumed or applied topically, designed to boost nicotinamide adenine dinucleotide (NAD+) levels in skin cells, thereby supporting cellular energy, repair mechanisms, and anti-aging processes to enhance skin health and appearance. For example, in November 2025, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen Beauty, which was the first NAD+ skincare supplement made available in the United States. This product features a precise combination of clinically studied ingredients, including its patented nicotinamide riboside (Niagen). This specific formulation aims to support cellular energy production, skin health, and overall well-being by increasing NAD+ availability, which naturally decreases with age.
Which Major Firms Are Strengthening Their Position In The Nicotinamide Adenine Dinucleotide Market?
Major companies operating in the nicotinamide adenine dinucleotide market are Thermo Fisher Scientific Inc., Life Extension Foundation Buyers Club Inc., Niagen Bioscience Inc., Tokyo Chemical Industry Co. Ltd., Otto Chemie Pvt. Ltd., HiMedia Laboratories Pvt. Ltd., Sichuan Benepure Pharmaceutical, F. Hoffmann-La Roche Ltd, Herbalmax Ltd., Nuray Chemicals Private Limited, Hefei Home Sunshine Pharmaceutical Technology Co. Ltd., Syncozymes Biotechnology Co. Ltd., OYC Americas Inc., Xi’an Yinherb Bio-Tech Co. Ltd., Shenzhen Hygieia Biotechnology Co. Ltd., Zhejiang Dazhan Biotechnology Co. Ltd., Willow Birch Pharma Inc., Hubei AOKS Bio-Tech Co. Ltd., Shanghai Neutan Pharmaceutical Co. Ltd., Evereen (Shanghai) Biotechnology Co. Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/nicotinamide-adenine-dinucleotide-market-report
Which Region Shows The Strongest Potential For Future Expansion In The Nicotinamide Adenine Dinucleotide Market?
North America was the largest region in the nicotinamide adenine dinucleotide market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide adenine dinucleotide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Nicotinamide Adenine Dinucleotide Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30680&type=smp
Browse Through More Reports Similar to the Global Nicotinamide Adenine Dinucleotide Market 2026, By The Business Research Company
Oligonucleotides Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report
Peptide And Oligonucleotide Cdmo Market Report 2026
n methyl 2 pyrrolidone nmp market
https://www.thebusinessresearchcompany.com/report/n-methyl-2-pyrrolidone-nmp-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model